Related Experiment Videos
Predicting early mortality following percutaneous stent insertion for malignant biliary obstruction: a multivariate
1University Department of Surgery, Royal Free and University College Medical School, London, UK.
European Journal of Gastroenterology & Hepatology
|November 1, 2000
Summary
Predicting early mortality after percutaneous stent placement for malignant biliary obstruction is possible. Key indicators include blood urea and hemoglobin levels, helping to identify high-risk patients for improved outcomes.
Area of Science:
- Medical procedures
- Gastroenterology
- Oncology
Background:
- Percutaneous stent placement is a standard palliative treatment for malignant biliary obstruction.
- Identifying factors for early mortality post-procedure is crucial for patient management.
Purpose of the Study:
- To identify risk factors for early mortality (≤30 days) in patients undergoing percutaneous stent placement for malignant biliary obstruction.
Main Methods:
- Retrospective study of 141 patients with malignant biliary obstruction.
- Analysis of 14 clinicopathological and laboratory variables.
- Stepwise logistic regression to identify independent predictors of mortality.
Main Results:
- Univariate analysis showed blood urea, albumin, hemoglobin, and alkaline phosphatase were significant.
- Hemoglobin level and blood urea independently predicted early mortality.
- 30-day mortality was 20.5%; patients with high blood urea and low hemoglobin had a 52% mortality rate.
Conclusions:
- Laboratory variables, specifically blood urea and hemoglobin, can predict mortality in malignant obstructive jaundice patients.
- A regression equation using blood urea and hemoglobin can estimate 30-day survival probability.